{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:44:22Z","timestamp":1792115062759,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["2T32AI007413"],"award-info":[{"award-number":["2T32AI007413"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK094775"],"award-info":[{"award-number":["T32DK094775"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA046592"],"award-info":[{"award-number":["P30 CA046592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA233476"],"award-info":[{"award-number":["R37CA233476"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA236722"],"award-info":[{"award-number":["R01CA236722"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neoplasms originating from thymic T-cell progenitors and post-thymic mature T-cell subsets account for a minority of lymphoproliferative neoplasms. These T-cell derived neoplasms, while molecularly and genetically heterogeneous, exploit transcription factors and signaling pathways that are critically important in normal T-cell biology, including those implicated in antigen-, costimulatory-, and cytokine-receptor signaling. The transcription factor GATA-3 regulates the growth and proliferation of both immature and mature T cells and has recently been implicated in T-cell neoplasms, including the most common mature T-cell lymphoma observed in much of the Western world. Here we show that GATA-3 is a proto-oncogene across the spectrum of T-cell neoplasms, including those derived from T-cell progenitors and their mature progeny, and further define the transcriptional programs that are GATA-3 dependent, which include therapeutically targetable gene products. The discovery that p300-dependent acetylation regulates GATA-3 mediated transcription by attenuating DNA binding has novel therapeutic implications. As most patients afflicted with GATA-3 driven T-cell neoplasms will succumb to their disease within a few years of diagnosis, these findings suggest opportunities to improve outcomes for these patients.<\/jats:p>","DOI":"10.1038\/s41408-022-00745-y","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T22:02:52Z","timestamp":1667512972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0682-5236","authenticated-orcid":false,"given":"Xiangrong","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9082-2117","authenticated-orcid":false,"given":"Chenguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-0333","authenticated-orcid":false,"given":"Pinki","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2120-024X","authenticated-orcid":false,"given":"Jonathan","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4488-347X","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5522-6694","authenticated-orcid":false,"given":"Badeia","family":"Saed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0452-945X","authenticated-orcid":false,"given":"Thilini","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Reneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sverdlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0340-2788","authenticated-orcid":false,"given":"Ashley","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-680X","authenticated-orcid":false,"given":"Nathanael G.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0428-8748","authenticated-orcid":false,"given":"Kedar","family":"Inamdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra C.","family":"Hristov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trilokraj","family":"Tejasvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2474-914X","authenticated-orcid":false,"given":"Carlos","family":"Barrionuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0914-9149","authenticated-orcid":false,"given":"Luis","family":"Taxa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8406-739X","authenticated-orcid":false,"given":"Sandro","family":"Casavilca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9228-3276","authenticated-orcid":false,"given":"J. Lu\u00eds Alberto","family":"de P\u00e1dua Covas Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6850-8247","authenticated-orcid":false,"given":"Hebert Fabr\u00edcio","family":"Culler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0655-2821","authenticated-orcid":false,"given":"Juliana","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6489-8575","authenticated-orcid":false,"given":"John S.","family":"Runge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lam C.","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-2808","authenticated-orcid":false,"given":"Hanna S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas A.","family":"Lyssiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8035-791X","authenticated-orcid":false,"given":"Rintaro","family":"Ohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6658-7543","authenticated-orcid":false,"given":"Tomomi","family":"Toubai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5314-8469","authenticated-orcid":false,"given":"Alejandro","family":"Zevallos-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-5066","authenticated-orcid":false,"given":"Carlos","family":"Murga-Zamalloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6420-0760","authenticated-orcid":false,"given":"Ryan A.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"745_CR1","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","volume":"123","author":"T Wang","year":"2014","unstructured":"Wang T, Feldman AL, Wada DA, Lu Y, Polk A, Briski R, et al. GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood 2014;123:3007\u201315.","journal-title":"Blood"},{"key":"745_CR2","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD, et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 2014;123:2915\u201323.","journal-title":"Blood"},{"key":"745_CR3","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-16-1996","volume":"23","author":"T Wang","year":"2017","unstructured":"Wang T, Lu Y, Polk A, Chowdhury P, Zamalloa CM, Fujiwara H, et al. T-cell receptor signaling activates an ITK\/NF-kappaB\/GATA-3 axis in T-cell lymphomas facilitating resistance to chemotherapy. Clin Cancer Res. 2017;23:2506\u201315.","journal-title":"Clin Cancer Res"},{"key":"745_CR4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.celrep.2012.10.012","volume":"2","author":"Y Chen","year":"2012","unstructured":"Chen Y, Bates DL, Dey R, Chen PH, Machado AC, Laird-Offringa IA, et al. DNA binding by GATA transcription factor suggests mechanisms of DNA looping and long-range gene regulation. Cell Rep. 2012;2:1197\u2013206.","journal-title":"Cell Rep"},{"key":"745_CR5","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jmb.2008.06.072","volume":"381","author":"DL Bates","year":"2008","unstructured":"Bates DL, Chen Y, Kim G, Guo L, Chen L. Crystal structures of multiple GATA zinc fingers bound to DNA reveal new insights into DNA recognition and self-association by GATA. J Mol Biol. 2008;381:1292\u2013306.","journal-title":"J Mol Biol"},{"key":"745_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40164-015-0024-z","volume":"4","author":"J Gao","year":"2015","unstructured":"Gao J, Chen YH, Peterson LC. GATA family transcriptional factors: emerging suspects in hematologic disorders. Exp Hematol Oncol. 2015;4:28.","journal-title":"Exp Hematol Oncol"},{"key":"745_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.immuni.2014.06.006","volume":"41","author":"I Tindemans","year":"2014","unstructured":"Tindemans I, Serafini N, Di Santo JP, Hendriks RW. GATA-3 function in innate and adaptive immunity. Immunity 2014;41:191\u2013206.","journal-title":"Immunity"},{"key":"745_CR8","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1084\/jem.20090934","volume":"206","author":"T Hosoya","year":"2009","unstructured":"Hosoya T, Kuroha T, Moriguchi T, Cummings D, Maillard I, Lim KC, et al. GATA-3 is required for early T lineage progenitor development. J Exp Med. 2009;206:2987\u20133000.","journal-title":"J Exp Med"},{"key":"745_CR9","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.0.CO;2-D","volume":"29","author":"RW Hendriks","year":"1999","unstructured":"Hendriks RW, Nawijn MC, Engel JD, van Doorninck H, Grosveld F, Karis A. Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur J Immunol. 1999;29:1912\u20138.","journal-title":"Eur J Immunol"},{"key":"745_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/384474a0","volume":"384","author":"CN Ting","year":"1996","unstructured":"Ting CN, Olson MC, Barton KP, Leiden JM. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 1996;384:474\u20138.","journal-title":"Nature"},{"key":"745_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ni.1647","volume":"9","author":"L Wang","year":"2008","unstructured":"Wang L, Wildt KF, Zhu J, Zhang X, Feigenbaum L, Tessarollo L, et al. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(+) T cells. Nat Immunol. 2008;9:1122\u201330.","journal-title":"Nat Immunol"},{"key":"745_CR12","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/ni1128","volume":"5","author":"J Zhu","year":"2004","unstructured":"Zhu J, Min B, Hu-Li J, Watson CJ, Grinberg A, Wang Q, et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol. 2004;5:1157\u201365.","journal-title":"Nat Immunol"},{"key":"745_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.cr.7310002","volume":"16","author":"J Zhu","year":"2006","unstructured":"Zhu J, Yamane H, Cote-Sierra J, Guo L, Paul WE. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res. 2006;16:3\u201310.","journal-title":"Cell Res"},{"key":"745_CR14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/ni.2623","volume":"14","author":"Y Wang","year":"2013","unstructured":"Wang Y, Misumi I, Gu AD, Curtis TA, Su L, Whitmire JK, et al. GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling. Nat Immunol. 2013;14:714\u201322.","journal-title":"Nat Immunol"},{"key":"745_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.immuni.2011.08.012","volume":"35","author":"Y Wang","year":"2011","unstructured":"Wang Y, Su MA, Wan YY. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 2011;35:337\u201348.","journal-title":"Immunity"},{"key":"745_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ni.3053","volume":"16","author":"F Yu","year":"2015","unstructured":"Yu F, Sharma S, Edwards J, Feigenbaum L, Zhu J. Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat Immunol. 2015;16:197\u2013206.","journal-title":"Nat Immunol"},{"key":"745_CR17","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","volume":"133","author":"TB Heavican","year":"2019","unstructured":"Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood 2019;133:1664\u201376.","journal-title":"Blood"},{"key":"745_CR18","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood.2019000779","volume":"134","author":"C Amador","year":"2019","unstructured":"Amador C, Greiner TC, Heavican TB, Smith LM, Galvis KT, Lone W, et al. Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry. Blood 2019;134:2159\u201370.","journal-title":"Blood"},{"key":"745_CR19","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41588-018-0191-z","volume":"50","author":"AD Durbin","year":"2018","unstructured":"Durbin AD, Zimmerman MW, Dharia NV, Abraham BJ, Iniguez AB, Weichert-Leahey N, et al. Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry. Nat Genet. 2018;50:1240\u20136.","journal-title":"Nat Genet"},{"key":"745_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s13058-014-0464-0","volume":"16","author":"H Cohen","year":"2014","unstructured":"Cohen H, Ben-Hamo R, Gidoni M, Yitzhaki I, Kozol R, Zilberberg A, et al. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer. Breast cancer Res: BCR. 2014;16:464.","journal-title":"Breast cancer Res: BCR"},{"key":"745_CR21","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/ajh.22139","volume":"86","author":"RA Wilcox","year":"2011","unstructured":"Wilcox RA. Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol. 2011;86:928\u201348.","journal-title":"Am J Hematol"},{"key":"745_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/ajh.25577","volume":"94","author":"AC Hristov","year":"2019","unstructured":"Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sezary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol. 2019;94:1027\u201341.","journal-title":"Am J Hematol"},{"key":"745_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4049\/jimmunol.167.2.715","volume":"167","author":"MC Nawijn","year":"2001","unstructured":"Nawijn MC, Ferreira R, Dingjan GM, Kahre O, Drabek D, Karis A, et al. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice. J Immunol. 2001;167:715\u201323.","journal-title":"J Immunol"},{"key":"745_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-016-0324-8","volume":"9","author":"L Fransecky","year":"2016","unstructured":"Fransecky L, Neumann M, Heesch S, Schlee C, Ortiz-Tanchez J, Heller S, et al. Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL. J Hematol Oncol. 2016;9:95.","journal-title":"J Hematol Oncol"},{"key":"745_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012;481:157\u201363.","journal-title":"Nature"},{"key":"745_CR26","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1172\/JCI37210","volume":"121","author":"X Wang","year":"2011","unstructured":"Wang X, Werneck MB, Wilson BG, Kim HJ, Kluk MJ, Thom CS, et al. TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest. 2011;121:3834\u201345.","journal-title":"J Clin Invest"},{"key":"745_CR27","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1182\/blood-2011-07-366070","volume":"119","author":"CJ Ku","year":"2012","unstructured":"Ku CJ, Hosoya T, Maillard I, Engel JD. GATA-3 regulates hematopoietic stem cell maintenance and cell-cycle entry. Blood 2012;119:2242\u201351.","journal-title":"Blood"},{"key":"745_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9470","volume":"6","author":"MJ Kiel","year":"2015","unstructured":"Kiel MJ, Sahasrabuddhe AA, Rolland DC, Velusamy T, Chung F, Schaller M, et al. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sezary syndrome. Nat Commun. 2015;6:8470.","journal-title":"Nat Commun"},{"key":"745_CR29","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1182\/blood.2021013568","volume":"139","author":"Y Kogure","year":"2022","unstructured":"Kogure Y, Kameda T, Koya J, Yoshimitsu M, Nosaka K, Yasunaga JI, et al. Whole-genome landscape of adult T-cell leukemia\/lymphoma. Blood 2022;139:967\u201382.","journal-title":"Blood"},{"key":"745_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2012.01.056","volume":"149","author":"JA Zhang","year":"2012","unstructured":"Zhang JA, Mortazavi A, Williams BA, Wold BJ, Rothenberg EV. Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity. Cell 2012;149:467\u201382.","journal-title":"Cell"},{"key":"745_CR31","doi-asserted-by":"publisher","first-page":"17876","DOI":"10.1073\/pnas.0909357106","volume":"106","author":"RG Jenner","year":"2009","unstructured":"Jenner RG, Townsend MJ, Jackson I, Sun K, Bouwman RD, Young RA, et al. The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. Proc Natl Acad Sci USA. 2009;106:17876\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"745_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.immuni.2010.04.004","volume":"32","author":"R Yagi","year":"2010","unstructured":"Yagi R, Junttila IS, Wei G, Urban JF Jr., Zhao K, Paul WE, et al. The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma. Immunity 2010;32:507\u201317.","journal-title":"Immunity"},{"key":"745_CR33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cell.2012.09.044","volume":"151","author":"G Vahedi","year":"2012","unstructured":"Vahedi G, Takahashi H, Nakayamada S, Sun HW, Sartorelli V, Kanno Y, et al. STATs shape the active enhancer landscape of T cell populations. Cell 2012;151:981\u201393.","journal-title":"Cell"},{"key":"745_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0960-9822(01)00623-6","volume":"12","author":"A Blokzijl","year":"2002","unstructured":"Blokzijl A, ten Dijke P, Ibanez CF. Physical and functional interaction between GATA-3 and Smad3 allows TGF-beta regulation of GATA target genes. Curr Biol. 2002;12:35\u201345.","journal-title":"Curr Biol"},{"key":"745_CR35","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1182\/blood-2015-02-625251","volume":"125","author":"RA Wilcox","year":"2015","unstructured":"Wilcox RA. Mogamulizumab: 2 birds, 1 stone. Blood 2015;125:1847\u20138.","journal-title":"Blood"},{"key":"745_CR36","doi-asserted-by":"publisher","first-page":"eaat0572","DOI":"10.1126\/science.aat0572","volume":"362","author":"QL Sievers","year":"2018","unstructured":"Sievers QL, Petzold G, Bunker RD, Renneville A, Slabicki M, Liddicoat BJ, et al. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science. 2018;362:eaat0572.","journal-title":"Science"},{"key":"745_CR37","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1016\/j.ejca.2013.04.029","volume":"49","author":"F Morschhauser","year":"2013","unstructured":"Morschhauser F, Fitoussi O, Haioun C, Thieblemont C, Quach H, Delarue R, et al. A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial. Eur J Cancer. 2013;49:2869\u201376.","journal-title":"Eur J Cancer"},{"key":"745_CR38","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","volume":"19","author":"YH Kim","year":"2018","unstructured":"Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, et al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2018;19:1192\u2013204.","journal-title":"Lancet Oncol"},{"key":"745_CR39","doi-asserted-by":"publisher","first-page":"114474","DOI":"10.18632\/oncotarget.22967","volume":"8","author":"C Murga-Zamalloa","year":"2017","unstructured":"Murga-Zamalloa C, Polk A, Hanel W, Chowdhury P, Brown N, Hristov AC, et al. Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas. Oncotarget 2017;8:114474\u201380.","journal-title":"Oncotarget"},{"key":"745_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ajh.24203","volume":"91","author":"RA Wilcox","year":"2016","unstructured":"Wilcox RA. A three-signal model of T-cell lymphoma pathogenesis. Am J Hematol. 2016;91:113\u201322.","journal-title":"Am J Hematol"},{"key":"745_CR41","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.4049\/jimmunol.0902544","volume":"185","author":"KD Cook","year":"2010","unstructured":"Cook KD, Miller J. TCR-dependent translational control of GATA-3 enhances Th2 differentiation. J Immunol. 2010;185:3209\u201316.","journal-title":"J Immunol"},{"key":"745_CR42","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1126\/science.284.5414.638","volume":"284","author":"EM Schaeffer","year":"1999","unstructured":"Schaeffer EM, Debnath J, Yap G, McVicar D, Liao XC, Littman DR, et al. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 1999;284:638\u201341.","journal-title":"Science"},{"key":"745_CR43","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/nm.3884","volume":"21","author":"WH Wilson","year":"2015","unstructured":"Wilson WH, Young RM, Schmitz R, Yang Y, Pittaluga S, Wright G, et al. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med. 2015;21:922\u20136.","journal-title":"Nat Med"},{"key":"745_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1215637","volume":"369","author":"JC Byrd","year":"2013","unstructured":"Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N. Engl J Med. 2013;369:32\u201342.","journal-title":"N. Engl J Med"},{"key":"745_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1470-2045(14)71182-9","volume":"16","author":"MZ Farooqui","year":"2015","unstructured":"Farooqui MZ, Valdez J, Martyr S, Aue G, Saba N, Niemann CU, et al. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. Lancet Oncol. 2015;16:169\u201376.","journal-title":"Lancet Oncol"},{"key":"745_CR46","doi-asserted-by":"publisher","first-page":"a002287","DOI":"10.1101\/cshperspect.a002287","volume":"2","author":"AH Andreotti","year":"2010","unstructured":"Andreotti AH, Schwartzberg PL, Joseph RE, Berg LJ. T-cell signaling regulated by the Tec family kinase, Itk. Cold Spring Harb Perspect Biol. 2010;2:a002287.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"745_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nri.2017.99","volume":"18","author":"GR Bantug","year":"2018","unstructured":"Bantug GR, Galluzzi L, Kroemer G, Hess C. The spectrum of T cell metabolism in health and disease. Nat Rev Immunol. 2018;18:19\u201334.","journal-title":"Nat Rev Immunol"},{"key":"745_CR48","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.15252\/embj.201796525","volume":"36","author":"T Xu","year":"2017","unstructured":"Xu T, Park SS, Giaimo BD, Hall D, Ferrante F, Ho DM, et al. RBPJ\/CBF1 interacts with L3MBTL3\/MBT1 to promote repression of Notch signaling via histone demethylase KDM1A\/LSD1. The. EMBO J. 2017;36:3232\u201349.","journal-title":"EMBO J"},{"key":"745_CR49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.201112098","volume":"196","author":"KJ Roux","year":"2012","unstructured":"Roux KJ, Kim DI, Raida M, Burke B. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol. 2012;196:801\u201310.","journal-title":"J Cell Biol"},{"key":"745_CR50","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1084\/jem.194.10.1461","volume":"194","author":"M Zhou","year":"2001","unstructured":"Zhou M, Ouyang W, Gong Q, Katz SG, White JM, Orkin SH, et al. Friend of GATA-1 represses GATA-3-dependent activity in CD4+ T cells. J Exp Med. 2001;194:1461\u201371.","journal-title":"J Exp Med"},{"key":"745_CR51","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1021\/cr500452k","volume":"115","author":"BM Dancy","year":"2015","unstructured":"Dancy BM, Cole PA. Protein lysine acetylation by p300\/CBP. Chem Rev. 2015;115:2419\u201352.","journal-title":"Chem Rev"},{"key":"745_CR52","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/25166","volume":"396","author":"J Boyes","year":"1998","unstructured":"Boyes J, Byfield P, Nakatani Y, Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 1998;396:594\u20138.","journal-title":"Nature"},{"key":"745_CR53","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1189\/jlb.0603389","volume":"75","author":"F Hayakawa","year":"2004","unstructured":"Hayakawa F, Towatari M, Ozawa Y, Tomita A, Privalsky ML, Saito H. Functional regulation of GATA-2 by acetylation. J Leukoc Biol. 2004;75:529\u201340.","journal-title":"J Leukoc Biol"},{"key":"745_CR54","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbrc.2018.02.120","volume":"497","author":"X Li","year":"2018","unstructured":"Li X, Jin J, Yang S, Xu W, Meng X, Deng H, et al. GATA3 acetylation at K119 by CBP inhibits cell migration and invasion in lung adenocarcinoma. Biochem Biophys Res Commun. 2018;497:633\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"745_CR55","doi-asserted-by":"publisher","first-page":"9828","DOI":"10.1074\/jbc.M707391200","volume":"283","author":"T Takaya","year":"2008","unstructured":"Takaya T, Kawamura T, Morimoto T, Ono K, Kita T, Shimatsu A, et al. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes. J Biol Chem. 2008;283:9828\u201335.","journal-title":"J Biol Chem"},{"key":"745_CR56","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1093\/emboj\/19.17.4676","volume":"19","author":"T Yamagata","year":"2000","unstructured":"Yamagata T, Mitani K, Oda H, Suzuki T, Honda H, Asai T, et al. Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs. The. EMBO J. 2000;19:4676\u201387.","journal-title":"EMBO J"},{"key":"745_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature24028","volume":"550","author":"LM Lasko","year":"2017","unstructured":"Lasko LM, Jakob CG, Edalji RP, Qiu W, Montgomery D, Digiammarino EL, et al. Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours. Nature 2017;550:128\u201332.","journal-title":"Nature"},{"key":"745_CR58","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","volume":"20","author":"T Narita","year":"2019","unstructured":"Narita T, Weinert BT, Choudhary C. Functions and mechanisms of non-histone protein acetylation. Nat Rev Mol Cell Biol. 2019;20:156\u201374.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"745_CR59","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.chembiol.2020.12.004","volume":"28","author":"R Vannam","year":"2021","unstructured":"Vannam R, Sayilgan J, Ojeda S, Karakyriakou B, Hu E, Kreuzer J, et al. Targeted degradation of the enhancer lysine acetyltransferases CBP and p300. Cell Chem Biol. 2021;28:503\u201314 e12.","journal-title":"Cell Chem Biol"},{"key":"745_CR60","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1074\/jbc.270.4.1515","volume":"270","author":"VM Smith","year":"1995","unstructured":"Smith VM, Lee PP, Szychowski S, Winoto A. GATA-3 dominant negative mutant. Functional redundancy of the T cell receptor alpha and beta enhancers. J Biol Chem. 1995;270:1515\u201320.","journal-title":"J Biol Chem"},{"key":"745_CR61","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41568-020-0247-0","volume":"20","author":"D Fiore","year":"2020","unstructured":"Fiore D, Cappelli LV, Broccoli A, Zinzani PL, Chan WC, Inghirami G. Peripheral T cell lymphomas: from the bench to the clinic. Nat Rev Cancer. 2020;20:323\u201342.","journal-title":"Nat Rev Cancer"},{"key":"745_CR62","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.4049\/jimmunol.1900959","volume":"205","author":"A Astori","year":"2020","unstructured":"Astori A, Tingvall-Gustafsson J, Kuruvilla J, Coyaud E, Laurent EMN, Sunnerhagen M, et al. ARID1a associates with lymphoid-restricted transcription factors and has an essential role in T cell development. J Immunol. 2020;205:1419\u201332.","journal-title":"J Immunol"},{"key":"745_CR63","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1182\/blood-2006-07-032847","volume":"108","author":"JM Lamonica","year":"2006","unstructured":"Lamonica JM, Vakoc CR, Blobel GA. Acetylation of GATA-1 is required for chromatin occupancy. Blood 2006;108:3736\u20138.","journal-title":"Blood"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00745-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T01:02:51Z","timestamp":1667696571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00745-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":63,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1038\/s41408-022-00745-y","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"28 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}